| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $543.5M | +2.9% | +28.8% |
| Cost of Revenue | $69.4M | +3.4% | +29.7% |
| Gross Profit | $474.1M | +2.8% | +28.7% |
| R&D Expense | $123.9M | -80.1% | +54.2% |
| SG&A Expense | $76.6M | -72.6% | +64.2% |
| Operating Income | -$64.7M | +93.0% | -111.2% |
| Pre-tax Income | -$54.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $445.0M | -48.7% | +64.3% |
| Accounts Receivable | $237.7M | +3.5% | — |
| Current Assets | $1.76B | +1.3% | — |
| Total Assets | $1.96B | +3.1% | — |
| Current Liabilities | $355.9M | -1.1% | — |
| Total Liabilities | $519.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $20.2M | — | — |
| Capital Expenditures | $5.7M | — | — |
| Investing Cash Flow | -$344.5M | — | — |
| Financing Cash Flow | $433.0M | — | — |
| Free Cash Flow | $14.5M | — | — |
| +94.1% |
| -174.6% |
| Income Tax | $280K | +126.7% | -87.3% |
| Net Income | -$54.7M | +94.1% | -148.4% |
| EPS (Basic) | -$0.15 | +97.9% | +55.9% |
| EPS (Diluted) | -$0.15 | +97.9% | +55.9% |
| +9.4% |
| — |
| Stockholders' Equity | $1.44B | +1.1% | +175.3% |